Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
05/2009
05/13/2009EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
05/13/2009EP1549624B1 Inhibitors of fatty acid amide hydrolase
05/12/2009US7531561 GSK-3 inhibitors
05/12/2009US7531533 6-Membered heterocyclic compound and use thereof
05/07/2009US20090118286 Heterobicyclic Acrylamides
05/07/2009US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
05/06/2009EP2054401A1 Thiophenecarboxamide derivatives as ep4 receptor ligands
05/06/2009EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors
05/06/2009EP2054056A2 Small molecule inhibitors of kynurenine-3-monooxygenase
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/06/2009CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient
05/06/2009CN100486030C Electrolytic solution and battery
05/06/2009CN100484944C N4-substited pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its preparation process and medicine composition
05/06/2009CN100484928C Thiadiazoline derivative
04/2009
04/30/2009WO2009011871A3 Thiadiazole modulators of pkb
04/30/2009WO2009010429A3 Novel heterocyclyl compounds and their use as chemokine antagonists
04/30/2009US20090111798 N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide;hepatitis C viral infections; hepatitis C NS5B polymerase inhibitors; enzyme inhibitors; viricides; side-effect reduction
04/30/2009US20090106915 Coloring hair non-oxidatively with pyridine dyes complexed with iron (II) ormanganese; 2-(Methyl-[2,2';6'2'']terpyridine-4'yl-amino)-ethanol ligand;no additional dye precursor needed, nor a pretreatment or a swelling agents;simplification
04/29/2009EP1771421B1 N-hydroxyamide derivatives and use thereof
04/29/2009CN101421256A Thiadiazolidinone inhibitors of ptpase
04/29/2009CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity
04/28/2009US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/28/2009US7524957 Compounds effecting glucokinase
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
04/23/2009WO2009052288A1 Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity
04/23/2009US20090105482 Urea Glucokinase Activators
04/23/2009US20090105474 Novel anthranilic acid derivative or salt thereof
04/23/2009US20090105473 PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS
04/23/2009US20090105306 Novel compounds as cannabinoid receptor ligands
04/23/2009US20090105230 Anti-inflammatory medicaments
04/23/2009CA2702922A1 Spiro-condensed 1,3,4-thiadiazole derivatives for inhibiting ksp kinesin activity
04/22/2009EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide
04/22/2009CN100480363C Thiadiazole additives and lubricating compositions containing the same
04/16/2009WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009US20090099242 Heterocyclic inhibitors of necroptosis
04/16/2009US20090099241 Pharmaceutical composition containing antihypertensive agents
04/16/2009US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/15/2009EP2046766A1 Agonists of the sphingosine- 1- phosphate receptor (slp)
04/15/2009EP2046760A1 Macrocyclic lactams
04/15/2009EP2046746A2 Chemical compounds
04/14/2009US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/14/2009US7517876 e.g. N-[3-(4-butyl-1,4-dihydroxy-3-oxo-3,4-dihydronaphthalen-2-yl)-1,1-dioxido-4H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide; viricide; hepatitis C (HCV) polymerase inhibitor; hepatitis , cirrhosis, end-stage liver disease, and liver cancer; side effect reduction
04/09/2009US20090093457 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
04/09/2009US20090091234 Room temperature molten salt and display element
04/09/2009CA2698928A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases
04/08/2009EP2044006A1 Insecticidal compounds
04/08/2009EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/02/2009WO2009040507A1 Substituted benamidines as antibacterial agents
04/02/2009WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
04/02/2009WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
04/01/2009CN101397281A Method for preparing 5-amino-1,2,3-thiadiazoles
03/2009
03/31/2009US7511149 Using ruthenium tetraoxide and alkali metal permanganate
03/31/2009US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
03/26/2009WO2009037485A1 Antibacterial agents
03/26/2009US20090082350 Soluble epoxide hydrolase inhibitors
03/25/2009EP2038267A2 Thiadiazolidinone inhibitors of ptpase
03/25/2009CN101395143A Aza heterocyclics for the treatment of malaria or aids
03/25/2009CN101392174A Soluble electro-green light organic molecule glass material and preparation method and use thereof
03/24/2009US7507860 Androgen modulators
03/24/2009US7507832 Triazole PPAR modulators
03/24/2009US7507700 Cleaning compounds; washing, rinsing fabrics, surfaces; reacting halohydrin with a substituted or unsubstituted 3,4-dihydroisoquinoline to form an alcohol salt; sulfating to produce iminium containing compound
03/19/2009WO2009034396A2 Method and means relating to multiple herbicide resistance in plants
03/19/2009US20090075986 Anti-inflammatory medicaments
03/19/2009CA2737047A1 Method and means relating to multiple herbicide resistance in plants
03/18/2009CN101389335A Thiadiazole compounds and methods of use.
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/12/2009WO2009030750A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090068378 Discotic nematic material, composition, retardation plate, elliptically-polarizing plate and compound
03/12/2009CA2698306A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/11/2009CN100467469C A2b adenosine receptor antagonists
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062286 Crystal Structure of SMYD3 Protein
03/05/2009US20090062263 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
03/04/2009CN101378757A Thiadiazole derivatives for the treatment of neuro degenerative diseases
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7498351 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/03/2009US7498325 Modified amino acids, pharmaceuticals containing these compounds and method for their production
03/03/2009US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/2009
02/26/2009WO2009025246A1 Method for production of purified ammonium salt of fluorinated bis-sulfonylimide
02/26/2009US20090054494 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide
02/19/2009WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia
02/19/2009WO2008047138A3 Histone deacetylase inhibitors
02/19/2009US20090048224 Compounds and methods of use
02/19/2009CA2696349A1 Heterocyclic inhibitors of necroptosis
02/18/2009EP1748994B1 Nitrooxyderivatives of antihypertensive drugs
02/17/2009US7491741 Diaminopropionic acid derivatives
02/12/2009WO2009019446A1 Compounds useful as medicaments
02/12/2009WO2009019445A1 Dithiazolidine and thiazolidine derivatives as anticancer agents
02/12/2009US20090042867 Compounds for the treatment of alzheimer's disease
02/12/2009US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control
02/12/2009CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/11/2009EP2021316A1 Inhibitors of polo-like kinases
02/11/2009CN101362737A 2-(4-substituted phenyl-1,2,3-thiadiazole-5sulfhydryl)-N-substituted phenyl acetamides derivates, preparation thereof and application
02/05/2009US20090032106 N-type conjugated materials based on 2-vinyl-4,5-dicyanoimidazoles and their use in organic photovoltaics
02/04/2009EP1551818B1 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 100